{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:30:13Z","timestamp":1787243413865,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.7759\/cureus.114868","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:22:17Z","timestamp":1787242937000},"source":"Crossref","is-referenced-by-count":0,"title":["Reversible Cerebral Vasoconstriction Syndrome Associated With Vortioxetine: A Case Report"],"prefix":"10.7759","author":[{"given":"Beatriz","family":"Fonseca Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Felgueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facia","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaclp.2021.07.013","article-title":"Reversible cerebral vasoconstriction syndrome associated with fluoxetine","volume":"62","author":"Manning T","year":"2021","unstructured":"Manning T, Bartow C, Dunlap M, Kiehl R, Kneale H, Walker A. Reversible cerebral vasoconstriction syndrome associated with fluoxetine. J Acad Consult Liaison Psychiatry. 2021, 62:634-44. 10.1016\/j.jaclp.2021.07.013","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.19.9.1159","article-title":"Reversible cerebral segmental vasoconstriction","volume":"19","author":"Call GK","year":"1988","unstructured":"Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke. 1988, 19:1159-70. 10.1161\/01.str.19.9.1159","journal-title":"Stroke"},{"key":"ref3","article-title":"Reversible Cerebral Vasoconstriction Syndromes","author":"Nesheiwat O","year":"2026","unstructured":"Nesheiwat O, Lui F, Al-Khoury L. Reversible Cerebral Vasoconstriction Syndromes. StatPearls Publishing , Treasure Island, FL; 2026."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm256","article-title":"The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients","volume":"130","author":"Ducros A","year":"2007","unstructured":"Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007, 130:3091-101. 10.1093\/brain\/awm256","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001082","article-title":"Vortioxetine-related call-Fleming syndrome","volume":"28","author":"Moodliar S","year":"2019","unstructured":"Moodliar S, Naguy A, AlKhadhari S. Vortioxetine-related call-Fleming syndrome. Am J Ther. 2019, 28:e258-60. 10.1097\/MJT.0000000000001082","journal-title":"Am J Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00857-4","article-title":"Pathophysiology of reversible cerebral vasoconstriction syndrome","volume":"29","author":"Chen SP","year":"2022","unstructured":"Chen SP, Wang SJ. Pathophysiology of reversible cerebral vasoconstriction syndrome. J Biomed Sci. 2022, 29:72. 10.1186\/s12929-022-00857-4","journal-title":"J Biomed Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2025.1864","article-title":"Reversible cerebral vasoconstriction syndrome secondary to escitalopram","volume":"22","author":"Postolowski M","year":"2024","unstructured":"Postolowski M, Shakil O, Ramachandran L, Rao CV. Reversible cerebral vasoconstriction syndrome secondary to escitalopram. Clin Med Res. 2024, 22:222-6. 10.3121\/cmr.2025.1864","journal-title":"Clin Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70135-7","article-title":"Reversible cerebral vasoconstriction syndrome","volume":"11","author":"Ducros A","year":"2012","unstructured":"Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012, 11:906-17. 10.1016\/S1474-4422(12)70135-7","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241267316","article-title":"Drugs associated with reversible cerebral vasoconstriction syndrome: a pharmacovigilance study in vigiBase(\u00ae)","volume":"44","author":"Favreli\u00e8re S","year":"2024","unstructured":"Favreli\u00e8re S, Mah\u00e9 J, Veyrac G, Neau JP, Lafay-Chebassier C, P\u00e9rault-Pochat MC. Drugs associated with reversible cerebral vasoconstriction syndrome: a pharmacovigilance study in vigiBase(\u00ae). Cephalalgia. 2024, 44:3331024241267316. 10.1177\/03331024241267316","journal-title":"Cephalalgia"},{"key":"ref10","article-title":"Cardiovascular side effects of newer antidepressants","volume":"7","author":"Fernandez A","year":"2007","unstructured":"Fernandez A, Bang SE, Srivathsan K, Vieweg WV. Cardiovascular side effects of newer antidepressants. Anadolu Kardiyol Derg. 2007, 7:305-9.","journal-title":"Anadolu Kardiyol Derg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-023-00607-9","article-title":"Reversible cerebral vasoconstriction syndrome: literature review","volume":"59","author":"Ribas MZ","year":"2023","unstructured":"Ribas MZ, Paticci\u00e9 GF, de Medeiros SD, de Oliveira Veras A, Noleto FM, Dos Santos JC. Reversible cerebral vasoconstriction syndrome: literature review. Egypt J Neurol Psychiatr Neurosurg. 2023, 59:5. 10.1186\/s41983-023-00607-9","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-5-548","article-title":"Reversible cerebral vasoconstriction syndrome in a patient taking citalopram and Hydroxycut: a case report","volume":"5","author":"Cvetanovich GL","year":"2011","unstructured":"Cvetanovich GL, Ramakrishnan P, Klein JP, Rao VR, Ropper AH. Reversible cerebral vasoconstriction syndrome in a patient taking citalopram and Hydroxycut: a case report. J Med Case Rep. 2011, 5:548. 10.1186\/1752-1947-5-548","journal-title":"J Med Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79917","article-title":"Reversible cerebral vasoconstriction syndrome secondary to paroxetine and opioid use in a middle-aged woman: a case report","volume":"17","author":"Simonsen E","year":"2025","unstructured":"Simonsen E, Joseph DN, Joseph N. Reversible cerebral vasoconstriction syndrome secondary to paroxetine and opioid use in a middle-aged woman: a case report. Cureus. 2025, 17:e79917. 10.7759\/cureus.79917","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/crnm\/4690032","article-title":"Posterior reversible encephalopathy syndrome induced by mirtazapine overdose: a case report","volume":"2025","author":"Tsai MC","year":"2025","unstructured":"Tsai MC, Lin WH. Posterior reversible encephalopathy syndrome induced by mirtazapine overdose: a case report. Case Rep Neurol Med. 2025, 2025:4690032. 10.1155\/crnm\/4690032","journal-title":"Case Rep Neurol Med"},{"key":"ref15","article-title":"Reversible cerebral vasoconstriction syndrome following smoking cessation and treatment with bupropion (Article in Spanish)","volume":"66","author":"De la Torre-Colmenero JD","year":"2018","unstructured":"De la Torre-Colmenero JD, Arjona-Padillo A, Fernandez-Perez J. Reversible cerebral vasoconstriction syndrome following smoking cessation and treatment with bupropion (Article in Spanish). Rev Neurol. 2018, 66:322-3.","journal-title":"Rev Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020531","article-title":"The role of vortioxetine in the treatment of depressive symptoms in General Hospital Psychiatry: a case-series and PRISMA-compliant systematic review of the literature","volume":"13","author":"Weiss F","year":"2024","unstructured":"Weiss F, Pacciardi B, D'Alessandro G, Caruso V, Maremmani I, Pini S, Perugi G. The role of vortioxetine in the treatment of depressive symptoms in General Hospital Psychiatry: a case-series and PRISMA-compliant systematic review of the literature. J Clin Med. 2024, 13:531. 10.3390\/jcm13020531","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42992","article-title":"Recurrent reversible cerebral vasoconstriction syndrome: a report of two cases","volume":"15","author":"Patel PA","year":"2023","unstructured":"Patel PA, Sanborn E, Then R, Williams DM. Recurrent reversible cerebral vasoconstriction syndrome: a report of two cases. Cureus. 2023, 15:e42992. 10.7759\/cureus.42992","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1586\/erc.10.124","article-title":"Systematic review of reversible cerebral vasoconstriction syndrome","volume":"8","author":"Sattar A","year":"2010","unstructured":"Sattar A, Manousakis G, Jensen MB. Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther. 2010, 8:1417-21. 10.1586\/erc.10.124","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001473","article-title":"Recurrence of reversible cerebral vasoconstriction syndrome: a long-term follow-up study","volume":"84","author":"Chen SP","year":"2015","unstructured":"Chen SP, Fuh JL, Lirng JF, Wang YF, Wang SJ. Recurrence of reversible cerebral vasoconstriction syndrome: a long-term follow-up study. Neurology. 2015, 84:1552-8. 10.1212\/WNL.0000000000001473","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415591507","article-title":"Long-term outcomes after reversible cerebral vasoconstriction syndrome","volume":"36","author":"John S","year":"2016","unstructured":"John S, Singhal AB, Calabrese L, et al.. Long-term outcomes after reversible cerebral vasoconstriction syndrome. Cephalalgia. 2016, 36:387-94. 10.1177\/0333102415591507","journal-title":"Cephalalgia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/516902-reversible-cerebral-vasoconstriction-syndrome-associated-with-vortioxetine-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:22:18Z","timestamp":1787242938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/516902-reversible-cerebral-vasoconstriction-syndrome-associated-with-vortioxetine-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.114868","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}